Glytech

Glytech

GlyTech is a science-driven biotechnology company focusing on bringing glycans into practical therapeutic use.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD14—21m (Dealroom.co estimates Apr 2013.)
Kyoto Kyoto Prefecture (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout
N/A

JPY296m

Series A

$5.8m

Series A

$1.5m

Early VC

$8.8m

Series A
N/A

JPY482m

Late VC

$6.8m

Late VC
Total FundingAUD44.7m

Recent News about Glytech

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.